Control of epidemics by jails: lessons for COVID-19 from HIV

• Type of Material: Article
• Authors: Tochi Ohuabunwa, Emory University; Anne Spaulding, Emory University
• Language: English
• Date: 2020-12-01
• Publisher: ELSEVIER INC
• Publication Version: Final Published Version
• Copyright Statement: © 2020 Elsevier Ltd. All rights reserved.
• Final Published Version (URL): http://dx.doi.org/10.1016/S2352-3018(20)30195-8
• Title of Journal or Parent Work: LANCET HIV
• Volume: 7
• Issue: 12
• Start Page: E798
• End Page: E799
• Keywords: Science & Technology; Infectious Diseases; Immunology; PRISONERS; Life Sciences & Biomedicine
• Research Categories: Biology, Virology; Health Sciences, Immunology

Abstract

Of the 10·2 million people incarcerated worldwide, an estimated 3·8% of individuals are HIV-positive, a proportion that varies widely by region.1 To achieve the ambitious UNAIDS 90-90-90 target,2 strategies must address incarcerated people with HIV, as well as those at liberty. Universal test-and-treat (UTT) interventions represent an important step towards achieving these goals; through earlier linkage to antiretroviral therapy (ART) and wider ART coverage among people with HIV, the spread of HIV could be prevented and potentially, the HIV/AIDS epidemic could be ended.3 However, progress towards the HIV/AIDS 90-90-90 targets has not been equally distributed across subpopulations, demographics, or regions. Incarcerated people are especially disadvantaged and at risk.